Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2005-04-30
2009-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Cognitive Motor Interference Rehabilitation in Persons With Multiple Sclerosis
NCT02274935
Influence of Exercise on the Mobility and Balance of Individuals With Multiple Sclerosis
NCT02524483
High-Intensity, Dynamic-stability Gait Training in People With Multiple Sclerosis
NCT05735691
Strength Training to Improve Gait in People With Multiple Sclerosis
NCT03175133
The Neural Mechanisms of Split-belt Treadmill Adaptation in People With Multiple Sclerosis
NCT05878873
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Three study visits to the MS Center at Evergreen; wearing a pedometer for two, one-week periods to record walking during regular daily activities; keeping a diary for any walking problems such as falls and slips.
Subjects must meet the following criteria:
Diagnosis of MS (any form); 18-70 years of age; be on stable MS treatment OR no MS treatment for the last three months; no scheduled hospitalization in the next six months.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Subject must have clinically definite MS according to McDonald criteria
* Subject must have EDSS between 0-6.5
* Subject must be aged 18-70
* Subjects must be given informed consent
* Subjects must be stable on disease modifying therapy or no therapy for at least three months before entry into study
Exclusion Criteria
* Subjects must have no scheduled major hospitalizations or surgical procedures during the study time frame. Hospitalization during the study may result in removal from the study
* Medical conditions other than MS that might significantly impact ambulatory activity (such as angina pectoris) in the judgement of the investigators
* History or suspicion of non-compliance in the judgement of the investigators
18 Years
70 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Brown, Theodore R., M.D., MPH
INDIV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
MS Center at Evergreen
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Theodore R Brown, MD, MPH
Role: PRINCIPAL_INVESTIGATOR
MS Center at Evergreen
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Pfizer Inc
Identifier Type: -
Identifier Source: secondary_id
Independent Grants 235-14-22
Identifier Type: -
Identifier Source: secondary_id
WIRB 20050607
Identifier Type: -
Identifier Source: org_study_id
NCT01355250
Identifier Type: -
Identifier Source: nct_alias
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.